Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q2 Results Top Estimates - Update

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) reported on Thursday that net income for the second quarter increased to $1.43 billion or $12.41 per share from $968 million or $8.50 per share in the prior-year quarter.

RTTNews | 440天前

Regeneron Pharma Expects Q4 Results To Include $24 Mln In Acquired In-process R&D Charge

Regeneron Pharmaceuticals, Inc. (REGN) said Monday it currently expects that its financial results for the second quarter 2024 will include an acquired in-process research and development charge of approximately $24 million on a pre-tax basis.

RTTNews | 464天前

Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

RTTNews | 474天前

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.

RTTNews | 1202天前

European Economic News Preview: UK GDP & Foreign Trade Data Due

National accounts and foreign trade data from the UK and final inflation from Italy are due on Thursday, headlining a light day for the European economic news.

RTTNews | 8分钟前

Sensex, Nifty Open Higher On Trade Talk Optimism

Indian shares traded higher on Thursday as talks on a bilateral trade agreement between India and the United States picked up pace.

RTTNews | 21分钟前

Australian Market Extends Early Gains In Mid-market

The Australian market is extending its early gains in mid-market moves on Thursday, adding to the gains in the previous two sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 9,050 mark to fresh all-time highs, with gains in gold miners, energy and financial stocks partially offset by weakness in technology stocks.

RTTNews | 1小时19分钟前

Asian Markets Trade Mostly Higher

Asian markets are trading mostly higher on Thursday, following the mixed cues from Wall Street overnight, amid positive hints of another rate cut in a speech by U.S. Fed Chair Jerome Powell as traders assessed the implications of escalating U.S.-China trade friction. Asian markets closed mostly higher on Wednesday.

RTTNews | 1小时30分钟前

EURUSD	1.1658	GBPUSD	1.34162	AUDUSD	0.64903
USDJPY	150.964	USDCAD	1.40329	USDCHF	0.79538